Angus M. MacLeod - Concepedia

Author

Angus M. MacLeod

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A. M. MACLEOD, A. M. MacLeod, A. M. Macleod, A. MACLEOD, A. MacLEOD, A. MacLeod, A.M. MACLEOD, A.M. MacLeod, A.M. Macleod, Angus M MacLeod

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)United States Military Academy Galapagos (Belgium)

About

Angus M. MacLeod is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	1.7K
2	Natural Sciences	17	20	994
3	Social Sciences	5	5	386
4	Engineering	4	4	185
5	Health Sciences	1	1	45

Angus M. MacLeod

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition Gerard R. Dawson, Karen Maubach, Neil Collinson, Journal of Pharmacology and Experimental Therapeutics	2006	240
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets F.D. Tattersall, Wayne Rycroft, B. Francis, Neuropharmacology Signal TransductionSignaling PathwayMedicineCell InteractionImmunology	1996	211
Novel quinuclidine-based ligands for the muscarinic cholinergic receptor John Saunders, Stephen B. Freedman, Elizabeth A. Harley, Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryMedicinal ChemistryAntagonist BehaviorBiochemistry	1990	157
Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT<sub>1D</sub> Receptor Ligands with Improved Pharmacokinetic Profiles Monique B. van Niel, Ian Collins, Margaret S. Beer, Journal of Medicinal Chemistry Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryPharmaceutical Science5-Ht1d Receptor Ligands	1999	157
Identification of a Novel, Selective GABA<sub>A</sub>α5 Receptor Inverse Agonist Which Enhances Cognition Mark S. Chambers, John Atack, Howard B. Broughton, Journal of Medicinal Chemistry NeurotransmitterPharmacotherapySynaptic SignalingSocial SciencesMolecular Pharmacology	2003	140
Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines Frank Wätjen, R. BAKER, Mogens Engelstoff, Journal of Medicinal Chemistry	1989	132
Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors L. J. STREET, R. BAKER, T. BOOK, Journal of Medicinal Chemistry	1990	132
A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ Hilde M. van der Schaar, Pieter Leyssen, Hendrik Jan Thibaut, Antimicrobial Agents and Chemotherapy	2013	113
3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT<sub>2A</sub> Receptor Antagonists Michael Rowley, David J. Hallett, Simon Goodacre, Journal of Medicinal Chemistry	2001	109
An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA<sub>A</sub> α5 Receptors with Cognition Enhancing Properties Mark S. Chambers, John Atack, Robert W. Carling, Journal of Medicinal Chemistry Psychotropic MedicationNeurotransmitterPsychopharmacologyInverse AgonistPharmacotherapy	2004	107

Page 1